Texmo Pipes & Products Ltd will hold a board meeting on Tuesday, October 13, 2026, to consider the allotment of 15,30,000 equity shares on a preferential basis to its promoters.

The meeting is scheduled for 4:00 pm at the company's registered office. This action is taken pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Insider trading window closure

In line with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company announced that the trading window will remain closed from October 1, 2026. The window is set to reopen 48 hours after the declaration of standalone and consolidated un-audited financial results for the quarter and half-year ended September 30, 2026.

This restriction applies to designated persons and their immediate relatives as per the company's code of conduct for preventing insider trading in equity shares.

Texmo Pipes & Products Limited received in-principle approval from the National Stock Exchange of India Ltd (NSE) and BSE Limited on September 29, 2026. This clearance paves the way for a preferential issue of 15,30,000 equity shares to proposed allottees.

The approval was granted under Regulation 28(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It also complies with applicable provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The company filed this disclosure in compliance with Regulation 30 read with Schedule III of the LODR Regulations and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.

Details of the Approval

The stock exchanges have cleared the allotment of up to 15,30,000 equity shares. This action is subject to compliance with all applicable laws, regulations, and conditions stipulated in the respective approval letters issued by NSE and BSE.

Impact and Utilization of Funds

The receipt of these approvals allows Texmo Pipes to proceed with the preferential issue and subsequent allotment. The proceeds from this capital raise will be utilized for purposes approved by shareholders. These objectives were detailed in the explanatory statement accompanying the notice convening the general meeting.

The validity of the approvals is tied to the terms and conditions specified in the letters from both exchanges. The company must ensure continued compliance with statutory requirements throughout the issuance process. There are currently no withdrawals, cancellations, or suspensions of this license or approval reported.